Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-28

Clinical Trial Update: Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis [Phase 3]

View source ↗

Summary

Phase 3 trial update for suprachoroidal CLS-TA injections in macular edema due to non-infectious uveitis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLS-TA (triamcinolone acetonide)

Snippet

Sponsor: Clearside Biomedical, Inc. | Conditions: Uveitis, Uveitis, Posterior | Phase 3 | Status: COMPLETED | Results posted: 2021-04-28